Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth Rosenberg

Showing results (41-50 of 45) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 45 results.
Oncotarget|August 31, 2015
Mutation of the BRCA1 SQ-cluster results in aberrant mitosis, reduced homologous recombination, and a compensatory increase in non-homologous end joiningJason M Beckta, Seth M Dever, Nisha Gnawali, et al.
Oncotarget|January 1, 2017
Correction: Mutation of the BRCA1 SQ-cluster results in aberrant mitosis, reduced homologous recombination, and a compensatory increase in non-homologous end joiningJason M Beckta, Seth M Dever, Nisha Gnawali, et al.
Molecular Cancer Therapeutics|July 29, 2003
MDA-7 (interleukin-24) inhibits the proliferation of renal carcinoma cells and interacts with free radicals to promote cell death and loss of reproductive capacityAdly Yacoub, Clint Mitchell, Jessica Brannon, et al.
Molecular Cancer Therapeutics|October 8, 2009
Improved ATM kinase inhibitor KU-60019 radiosensitizes glioma cells, compromises insulin, AKT and ERK prosurvival signaling, and inhibits migration and invasionSarah E Golding, Elizabeth Rosenberg, Nicholas Valerie, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 27, 2013
ATM kinase inhibition preferentially sensitizes p53-mutant glioma to ionizing radiationLaura Biddlestone-Thorpe, Muhammad Sajjad, Elizabeth Rosenberg, et al.
Pageof 5

Showing results (41-50 of 45) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 45 results.
Oncotarget|August 31, 2015
Mutation of the BRCA1 SQ-cluster results in aberrant mitosis, reduced homologous recombination, and a compensatory increase in non-homologous end joiningJason M Beckta, Seth M Dever, Nisha Gnawali, et al.
Oncotarget|January 1, 2017
Correction: Mutation of the BRCA1 SQ-cluster results in aberrant mitosis, reduced homologous recombination, and a compensatory increase in non-homologous end joiningJason M Beckta, Seth M Dever, Nisha Gnawali, et al.
Molecular Cancer Therapeutics|July 29, 2003
MDA-7 (interleukin-24) inhibits the proliferation of renal carcinoma cells and interacts with free radicals to promote cell death and loss of reproductive capacityAdly Yacoub, Clint Mitchell, Jessica Brannon, et al.
Molecular Cancer Therapeutics|October 8, 2009
Improved ATM kinase inhibitor KU-60019 radiosensitizes glioma cells, compromises insulin, AKT and ERK prosurvival signaling, and inhibits migration and invasionSarah E Golding, Elizabeth Rosenberg, Nicholas Valerie, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 27, 2013
ATM kinase inhibition preferentially sensitizes p53-mutant glioma to ionizing radiationLaura Biddlestone-Thorpe, Muhammad Sajjad, Elizabeth Rosenberg, et al.
Pageof 5